SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-010602
Filing Date
2016-06-08
Accepted
2016-06-07 17:42:36
Documents
69
Period of Report
2016-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 454135
2 ex31-1.htm EX-31.1 18466
3 ex31-2.htm EX-31.2 18455
4 ex32-1.htm EX-32.1 8757
5 ex32-2.htm EX-32.2 8460
  Complete submission text file 0001493152-16-010602.txt   3238623

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE adxs-20160430.xml EX-101.INS 543991
7 XBRL SCHEMA FILE adxs-20160430.xsd EX-101.SCH 44886
8 XBRL CALCULATION FILE adxs-20160430_cal.xml EX-101.CAL 60063
9 XBRL DEFINITION FILE adxs-20160430_def.xml EX-101.DEF 120057
10 XBRL LABEL FILE adxs-20160430_lab.xml EX-101.LAB 317621
11 XBRL PRESENTATION FILE adxs-20160430_pre.xml EX-101.PRE 230074
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 161702201
SIC: 2834 Pharmaceutical Preparations